Araki Y*, Rajkovich K*, Gerber EE*, Gamache T*, Johnson RE, Tran T, Liu B, Hong I, Kirkwood A, Huganir R. SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity. Science. 2024 Mar;383(6686):eadk1291. PMID: 38422154.
*equal contribution
Araki Y*, Gerber EE*, Rajkovich K*, Hong I*, Johnson R, Lee H, Kirkwood A, Huganir R. Mouse models of SYNGAP1-related intellectual disability. Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2308891120. PMID: 37669379.
*equal contribution
Gerber EE, Gallo EM, Fontana SC, Davis EC, Wigley FM, Huso DL, Dietz HC. Integrin Modulating Therapies Prevent Fibrosis and Autoimmunity in Genetic Mouse Models of Scleroderma. Nature. 2013: 503(7474),126-30. PMID: 24107997.
Chen X, Marsh JD, Zafar S, Gerber EE, Guyton DL. Increasing incidence and risk factors for divergence insufficiency esotropia. J AAPOS. 2021 Oct: 25(5):278.e1-278.e6. PMID: 34582959.
Rouf R, MacFarlane EG, Takimoto E, Chaudhary R, Nagpal V, Rainer PP, Bindman JG, Gerber EE, Bedja D, Schiefer C, Miller KL, Zhu G, Myers L, Amat-Alarcon N, Lee DI, Koitabashi N, Judge DP, Kass DA, Dietz HC. Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice. JCI Insight. 2017 Aug 3: 2(15). PMID: 28768908.
Bjornsson HT,* Benjamin JS,* Zhang L, Weissman J, Gerber EE, Chen YC, Vaurio RG, Potter MC, Hanson KD, Dietz HC. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med. 2014: 6(256):256ra135. PMID: 25273096.
*equal contribution.
Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, van Erp C, Gerber EE, Parker SJ, Sauls K, Judge DP, Cooke SK, Lindsay ME, Rouf R, Myers L, Ap Rhys CM, Kent KC, Norris RA, Huso DL, Dietz HC. Angiotensin II-Dependent TGF-Beta Signaling Contributes to the Vascular Pathogenesis of Loeys-Dietz syndrome. J Clin Invest. 2014: 124(1), 448–460. PMID: 4355923.
Doyle JJ, Gerber EE, Dietz HC. Matrix-dependent perturbation of TGF-Beta signaling and disease. FEBS Lett. 2012: 586(14), 2003-15. PMID: 22641039.
Gerber EE and Dietz HC. Chapter 22. Fibrosis: Insights from the Stiff Skin Syndrome. In Varga, J, Denton, C.P., Wigley, F.M. eds. Scleroderma. From Pathogenesis to Comprehensive Management, 1st edition. New York, NY: Springer US; 2012: 267-282.
Loeys BL,* Gerber EE,* Riegert-Johnson D,* Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai LY, Dietz HC. Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med. 2010: 2(23), 23ra20. PMID: 20375004.
*equal contribution.
The Gerber Lab supports and welcomes learners of all backgrounds. We believe in cultivating an open-minded curiosity about our world and that this requires us to understand how our perceptions and biases shape our perspectives. We are committed to building a laboratory and training environment that is diverse and inclusive – to welcome, and collectively benefit from, unique perspectives on both science and life.